Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock

超越數字：7位分析師討論Castle Biosciences股票

Benzinga · 01/02 21:02

Across the recent three months, 7 analysts have shared their insights on Castle Biosciences (NASDAQ:CSTL), expressing a variety of opinions spanning from bullish to bearish.

在最近的三個月裏，7位分析師分享了他們對Castle Biosciences（納斯達克：CSTL）的看法，表達了從看好到看淡的各種意見。

Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.

總結他們最近的評估，下面的表格顯示了過去30天裏情緒的變化，並將其與之前的月份進行了比較。

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $40.29, with a high estimate of $44.00 and a low estimate of $36.00. This upward trend is evident, with the current average reflecting a 14.17% increase from the previous average price target of $35.29.

分析師對12個月價格目標的評估提供了額外的見解，顯示出平均目標爲40.29美元，最高估計爲44.00美元，最低估計爲36.00美元。這個上升趨勢顯而易見，目前的平均水平反映出比之前的平均價格目標35.29美元增加了14.17%。

Exploring Analyst Ratings: An In-Depth Overview

分析師評級:深入了解

The analysis of...

對近期...

登入免費觀看全文

登入/註冊

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock

Beyond The Numbers: 7 Analysts Discuss Castle Biosciences Stock

風險及免責聲明

聲明